Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
The Role ofInternational journal of molecular sciences · 2026
Review
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Yun-Hong SunInstitute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.ORCID 0009-0000-7050-8940
Pei-Lun DingInstitute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
Xue WangInstitute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
Yi-Rong WangInstitute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
Ming-Zhe ZhuSchool of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.ORCID 0000-0001-7238-6414
Kai WangExperiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Liang DaiInstitute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
Yan-Qi DangInstitute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.ORCID 0000-0002-0316-7880
Guang JiInstitute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
Meng LiInstitute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.ORCID 0000-0002-3602-3429
Wen-Jun ZhouInstitute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.ORCID 0000-0003-4167-0337
Funding
National Natural Science Foundation of China 81620108030Postdoctoral Fellowship Program of CPSF GZB20250905State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine LSLSKL20240130
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Lingguizhugan Decoction Ameliorates MASLD by Modulating the Gut Microbiota and Enriching Non-12-OH Bile Acids to Activate TGR5-Mediated Thermogenesis. · full record | OpenQuestion